Skip to main content
Log in

The Added Value of Embryo Cryopreservation to Cumulative Ongoing Pregnancy Rates Per IVF Treatment: Is Cryopreservation Worth the Effort?

  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose : To calculate the added benefit of a cryopreservation program to the cumulative ongoing pregnancy rate over a maximum of three cycles of IVF.

Methods : A total of 1251 couples beginning their first IVF treatment between January 1995 and December 1999 were evaluated. Ongoing pregnancies from fresh and subsequent cryopreserved embryo transfer cycles were analyzed. Pregnancies arising from the cryopreservation cycle were considered to augment the cumulative pregnancy rate when no ongoing pregnancy arose from the fresh embryo transfer cycle.

Results : The ongoing pregnancy rate per cryopreserved embryo transfer was 11.7%. The cumulative ongoing pregnancy rate following three successive started fresh IVF cycles was 42.5%. When pregnancies arising from the transfer of thawed cryopreserved embryos were included, the cumulative ongoing pregnancy rate increased to 43.8%, rising to 44.8% when extrapolated data from as yet unthawed embryos was included.

Conclusions : When analyzed in these terms, the supplementary benefit of cryopreserving supranumerical embryos appears limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Trounson A, Mohr L: Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 1983;305:707–709

    Google Scholar 

  2. Zeilmaker GH, Alberda AT, van Gent I, Rijkmans CM, Drogendijk AC: Two pregnancies following transfer of intact frozen–thawed embryos. Fertil Steril 1984;42:293–296

    Google Scholar 

  3. The American Fertility Society: Revised minimum standards for in vitro fertilization, gamete intrafallopian transfer, and related procedures. Fertil Steril 1990;53:225–226

    Google Scholar 

  4. Fugger EF: Clinical status of human embryo cryopreservation in the United States of America. Fertil Steril 1989;52:986–990

    Google Scholar 

  5. Quigley MM, Wolf DP, Maklad NF, Dandekar PV, Sokoloski JE: Follicular size and number in human in vitro fertilization. Fertil Steril 1982;38:678–681

    Google Scholar 

  6. MacDougall MJ, Tan SL, Hall V, Balen A, Mason BA, Jacobs HS: Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: A prospective, randomized trial. Fertil Steril 1994;61:1052–1057

    Google Scholar 

  7. Tan SL, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, Yovich J, Jacobs HS: The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992;57:810–814

    Google Scholar 

  8. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van deKoppel P, Collins JA: The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: A meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888–896

    Google Scholar 

  9. Schieve LA, Peterson HB, Meikle SF, Jeng G, Danel I, Burnett NM, Wilcox LS: Live-birth rates and multiple-birth risk using in vitro fertilization. JAMA 1999;282:1832–1838

    Google Scholar 

  10. Mandelbaum J, Belaisch-Allart J, Junca AM, Antoine JM, Plachot M, Alvarez S, Alnot MO, Salat-Baroux J: Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes. Hum Reprod 1998;13(Suppl 3):161–174

    Google Scholar 

  11. Edwards RG, Lobo R, Bouchard P: Time to revolutionize ovarian stimulation. Hum Reprod 1996;11:917–919

    Google Scholar 

  12. Olivennes F, Frydman R: Friendly IVF: The way of the future? Hum Reprod 1998;13:1121–1124

    Google Scholar 

  13. Fauser BC, Devroey P, Yen SS, Gosden R, Crowley WF Jr, Baird DT, Bouchard P: Minimal ovarian stimulation for IVF: Appraisal of potential benefits and drawbacks. Hum Reprod 1999;14:2681–2686

    Google Scholar 

  14. De Vries MJ, De Sutter P, Dhont M: Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts. Fertil Steril 1999;72:674–678

    Google Scholar 

  15. Osmanagaoglu K, Tournaye H, Camus M, Vandervorst M, Van Steirteghem A, Devroey P: Cumulative delivery rates after intracytoplasmic sperm injection: 5 year follow-up of 498 patients. Hum Reprod 1999;14:2651–2655

    Google Scholar 

  16. Schenker JG: Assisted reproduction practice in Europe: Legal and ethical aspects. Hum Reprod Update 1997;3:173–184

    Google Scholar 

  17. Fasouliotis SJ, Schenker JG: Cryopreservation of embryos: Medical, ethical, and legal issues. J Assist Reprod Genet 1996;13:756–761

    Google Scholar 

  18. Jones HWJ, Veeck LL, Muasher SJ: Cryopreservation: The problem of evaluation. Hum Reprod 1995;10:2136–2138

    Google Scholar 

  19. Van der Elst J, Camus M, Van den Abbeel E, Maes R, Devroey P, Van Steirteghem AC: Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols. Fertil Steril 1995;63:92–100

    Google Scholar 

  20. Van Steirteghem AC, Van der Elst J, Van den Abbeel E, Joris H, Camus M, Devroey P: Cryopreservation of supernumerary multicellular human embryos obtained after intracytoplasmic sperm injection. Fertil Steril 1994;62:775–780

    Google Scholar 

  21. Macklon NS, Pieters MH, Fauser BCJM: Indications for IVF treatment: from diagnosis to prognosis. In Textbook of Assisted Reproductive Techniques, DK Gardner, A Weissman, CM Howles, Z Shoham (eds), London, Martin Dunitz, 2001,pp 393–400.

    Google Scholar 

  22. Huisman GJ, Fauser BC, Eijkemans MJ, Pieters MH: Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of culture. Fertil Steril 2000;73:117–122

    Google Scholar 

  23. Hunault CC, Eijkemans MJ, Pieters MH, te Velde ER, Habbema JD, Fauser BC, Macklon NS:Aprediction model for selecting patients for elective single embryo transfer in IVF. Fertil Steril 2002;77:725–732

    Google Scholar 

  24. Veeck LL: Preembryo grading and degree of cytoplasmic fragmentation. In An Atlas of Human Gametes and Conceptuses, LL Veeck (ed), New York, Parthenon Publishing, 1998, pp 40–45.

    Google Scholar 

  25. Jones HWJ, Jones D, Kolm P: Cryopreservation: A simplified method of evaluation. Hum Reprod 1997;12:548–553

    Google Scholar 

  26. Muenz LR, Rubinstein LV: Markov models for covariate dependence of binary sequences. Biometrics 1985;41:91–101

    Google Scholar 

  27. The ganirelix dose-finding study group: A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum Reprod 1998;13:3023–3031

    Google Scholar 

  28. The European Orgalutran Study group, BormG, Mannaerts B: Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial. Hum Reprod 2000;15:1490–1498

    Google Scholar 

  29. The European IVF-monitoring programme (EIM), Nygren K, Nyboe Andersen A for the European Society of Human Reproduction and Embryology (ESHRE): Assisted reproductive technology in Europe, 1997. Results generated from European registers by ESHRE. Hum Reprod 2001;16:384–391

  30. Ludwig M, Al-Hasani S, Felberbaum R, Diedrich K: No impact of cryopreservation on embryo development potential—one more example of the problems of retrospective, non-controlled data. Hum Reprod 1998;13:786–787

    Google Scholar 

  31. Testart J: Episcientific aspects of the epigenetic factors in arti-ficial procreation. Hum Reprod 1998;13:783–785

    Google Scholar 

  32. Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine: Assisted reproductive technology in the United States: 1997 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2000;74:641–654

    Google Scholar 

  33. Van den Abbeel E, Van Steirteghem A: Zona pellucida damage to human embryos after cryopreservation and the consequences for their blastomere survival and in-vitro viability. Hum Reprod 2000;15:373–378

    Google Scholar 

  34. Jones HWJ, Out HJ, Hoomans EH, Driessen SG, Coelingh Bennink HJ: Cryopreservation: The practicalities of evaluation. Hum Reprod 1997;12:1522–1524

    Google Scholar 

  35. Van der Elst J, Van den Abbeel E, Camus M, Smitz J, Devroey P, Van Steirteghem A: Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG. Hum Reprod 1996;11:2097–2106

    Google Scholar 

  36. Edgar DH, Bourne H, Spiers AL, McBain JC: A quantative analysis of the impact of cryopreservation on the implantation potential of human early cleavage stage embryos.HumReprod 2000;15:175–179

    Google Scholar 

  37. Fauser BC, Bouchard P, Coelingh Bennink HJ, Collins JA, Devroey P, Evers JL, Van Steirteghem A: Alternative approaches in IVF. Hum Reprod Update 2002;8:1–9

    Google Scholar 

  38. Troup SA, Matson PL, Critchlow JD, Morroll DR, Lieberman BA, Burslem RW: Cryopreservation of human embryos at the pronucleate, early cleavage, or expanded blastocyst stages. Eur J Obstet Gynecol Reprod Biol 1991;38:133–139

    Google Scholar 

  39. Kaufman RA, Menezo Y, Hazout A, Nicollet B, DuMont Mm, Servy EJ: Cocultured blastocyst cryopreservation: Experience of more than 500 transfer cycles. Fertil Steril 1995;64:1125–1129

    Google Scholar 

  40. Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine: Assisted reproductive technology in the United States: 1998 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 2002;77:18–31

    Google Scholar 

  41. Eugster A, Vingerhoets AJ: Psychological aspects of in vitro fertilization: A review. Soc Sci Med 1999;48:575–589

    Google Scholar 

  42. Shannon TA: Ethical issues involved with in vitro fertilization. AORN J 1990;52:627–631

    Google Scholar 

  43. de Jong D, Macklon NS, Fauser BC: A pilot study involving minimal ovarian stimulation for in vitro fertilization: Extending the “follicle-stimulating hormone window” combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril 2000;73:1051–1054

    Google Scholar 

  44. Macklon NS, Fauser BCJM: Alternative approaches to ovarian stimulation for IVF. Reprod Med Rev 2001;9:77–89

    Google Scholar 

  45. Hojgaard A, Ingerslev HJ, Dinesen: Friendly IVF: Patient opinions. Hum Reprod 2001;16:1391–1396

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N. S. Macklon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Jong, D., Eijkemans, M.J.C., Beckers, N.G.M. et al. The Added Value of Embryo Cryopreservation to Cumulative Ongoing Pregnancy Rates Per IVF Treatment: Is Cryopreservation Worth the Effort?. J Assist Reprod Genet 19, 561–568 (2002). https://doi.org/10.1023/A:1021211115337

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021211115337

Navigation